577nm微脉冲激光与药物治疗中心性浆液性脉络膜视网膜病变
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Efficacy comparison of 577nm micro-pulse laser and drug in the treatment of central serous chorioretinopathy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:比较577nm微脉冲激光与药物治疗中心性浆液性脉络膜视网膜病变(central serous chorioretinopathy,CSC)的疗效。

    方法:选择我院2012-01-01/09-31的CSC患者45例45眼为激光组,行577nm微脉冲激光治疗,并与药物组(40例40眼)的疗效比较。

    结果:激光组于治疗后6wk全部治愈,比药物治疗组恢复时间更短,见效更快。

    结论:577nm微脉冲激光治疗CSC是安全有效的,并可减少CSC的复发。

    Abstract:

    AIM: To compare the efficacy of 577nm micro-pulse laser and drug in the treatment of central serous chorioretinopathy(CSC).

    METHODS: Forty-five CSC cases(45 eyes), in our hospital from January 1, 2012 to September 31, 2012, were received 577nm micro-pulse laser in laser group. Forty cases(40 eyes)got drug in drug group. The efficacy of two groups was compared.

    RESULTS: All eyes in laser group were cured at 6 weeks after treatment, which was shorter than that in drug group.

    CONCLUSION: 577nm micro-pulse laser treatment for CSC is safe and effective, and can reduce the recurrence of CSC.

    参考文献
    相似文献
    引证文献
引用本文

徐斌.577nm微脉冲激光与药物治疗中心性浆液性脉络膜视网膜病变.国际眼科杂志, 2013,13(8):1688-1690.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2013-03-29
  • 最后修改日期:2013-07-15
  • 录用日期:
  • 在线发布日期: 2013-07-29
  • 出版日期:
文章二维码